William R Sellers

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Nature chemical biology

Cancer research

Nature genetics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Chang, Nancy Y Jung, Adel Atari, Diego J Rodriguez, Devishi Kesar, Tian-Yu Song, Matthew G Rees, Melissa A Ronan, Ruitong Li, Paloma A Ruiz, Saireudee Chaturantabut, Takahiro Ito, Laurens M van Tienen, Yuen-Yi Tseng, Jennifer A Roth, William R Sellers
Author Correction: Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities. Nature genetics (2024)
Hai-Tsang Huang, Ryan J Lumpkin, Ryan W Tsai, Shuyao Su, Xu Zhao, Yuan Xiong, James Chen, Nada Mageed, Katherine Aleisha Donovan, Eric S Fischer, William R Sellers
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nature chemical biology (2024)
Hai-Tsang Huang, Ryan J Lumpkin, Ryan W Tsai, Shuyao Su, Xu Zhao, Yuan Xiong, James Chen, Nada Mageed, Katherine Aleisha Donovan, Eric S Fischer, William R Sellers
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nature chemical biology 20 (9) (2024)
Hai-Tsang Huang, Ryan J Lumpkin, Ryan W Tsai, Shuyao Su, Xu Zhao, Yuan Xiong, James Chen, Nada Mageed, Katherine Aleisha Donovan, Eric S Fischer, William R Sellers
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nature chemical biology 20 (9) (2024)
Liang Chang, Nancy Y Jung, Adel Atari, Diego J Rodriguez, Devishi Kesar, Tian-Yu Song, Matthew G Rees, Melissa A Ronan, Ruitong Li, Paloma A Ruiz, Saireudee Chaturantabut, Takahiro Ito, Laurens M van Tienen, Yuen-Yi Tseng, Jennifer A Roth, William R Sellers
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities. Nature genetics (2023)
Ruitong Li, Olaf Klingbeil, Davide Monducci, Michael J Young, Diego J Rodriguez, Zaid Bayyat, Joshua M Dempster, Devishi Kesar, Xiaoping Yang, Mahdi Zamanighomi, Christopher R Vakoc, Takahiro Ito, William R Sellers
Comparative optimization of combinatorial CRISPR screens. Nature communications 13 (1) (2022)
Francisca Vazquez, William R Sellers
Are CRISPR Screens Providing the Next Generation of Therapeutic Targets? Cancer research 81 (23) (2022)
Daniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, Thomas A Skipper, Thomas C Atack, Nolan Bick, Meilani Ching, Andrew A Guirguis, Jason Kwon, Carly Langan, Dylan Millson, Brenton R Paolella, Kevin Tran, Sarah J Wie, Francisca Vazquez, Zuzana Tothova, Todd R Golub, William R Sellers, Alessandra Ianari
Systematic profiling of conditional degron tag technologies for target validation studies. Nature communications 13 (1) (2022)
Takahiro Ito, Michael J Young, Ruitong Li, Sidharth S Jain, Andreas Wernitznig, John Michael Krill-Burger, Christopher T Lemke, Davide Monducci, Diego J Rodriguez, Liang Chang, Sanjukta Dutta, Debjani Pal, Brenton R Paolella, Michael V Rothberg, David E Root, Cory M Johannessen, Laxmi Parida, Gad A Getz, Francisca Vazquez, John G Doench, Mahdi Zamanighomi, William R Sellers
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nature genetics 53 (12) (2021)
Adam C Palmer, Deborah Plana, Hui Gao, Joshua M Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E McLaughlin, David A Ruddy, Colleen Kowal, Julie Muszynski, Caroline Bullock, Stacy Rivera, Daniel P Rakiec, GiNell Elliott, Paul Fordjour, Ronald Meyer, Alice Loo, Esther Kurth, Jeffrey A Engelman, Hans Bitter, William R Sellers, Juliet A Williams, Peter Karl Sorger
A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts. Cancer research 80 (19) (2020)
Sabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, Huai-Xiang Hao, Angela Tam, Hui Qin Wang, Jinsheng Liang, Matthew T DiMare, Hyo-Eun Carrie Bhang, Youzhen Wang, Pascal Furet, William R Sellers, Francesco Hofmann, Joseph Schoepfer, Ralph Tiedt
Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (10) (2019)
Mahdi Zamanighomi, Sidharth S Jain, Takahiro Ito, Debjani Pal, Timothy P Daley, William R Sellers
GEMINI: a variational Bayesian approach to identify genetic interactions from combinatorial CRISPR screens. Genome biology 20 (1) (2019)
Andreas Weiss, Flavia Adler, Alexandra Buhles, Christelle Stamm, Robin A Fairhurst, Michael Kiffe, Dario Sterker, Mario Centeleghe, Markus Wartmann, Jacqueline Kinyamu-Akunda, Heiko S Schadt, Philippe Couttet, Armin Wolf, Youzhen Wang, Patrizia Barzaghi-Rinaudo, Masato Murakami, Audrey Kauffmann, Thomas Knoepfel, Nicole Buschmann, Catherine Leblanc, Robert Mah, Pascal Furet, Jutta Blank, Francesco Hofmann, William R Sellers, Diana Graus Porta
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer. Molecular cancer therapeutics 18 (12) (2019)
Haoxin Li, Kevin Bullock, Carino Gurjao, David Braun, Sachet A Shukla, Dominick Bosse, Aly-Khan A Lalani, Shuba Gopal, Chelsea Jin, Christine Horak, Megan Wind-Rotolo, Sabina Signoretti, David F McDermott, Gordon J Freeman, Eliezer Van Allen, Stuart L Schreiber, F Stephen Hodi, William R Sellers, Levi A Garraway, Andrew T Chan, Toni K Choueiri, Marios Giannakis
Metabolomic adaptations and correlates of survival to immune checkpoint blockade. Nature communications 10 (1) (2019)
Sébastien Jeay, Stéphane Ferretti, Philipp Holzer, Jeanette Fuchs, Emilie A Chapeau, Markus Wartmann, Dario Sterker, Vincent Romanet, Masato Murakami, Grainne Kerr, Eric Y Durand, Swann Gaulis, Marta Cortes-Cros, Stephan Ruetz, Therese-Marie Stachyra, Joerg Kallen, Pascal Furet, Jens Würthner, Nelson Guerreiro, Ensar Halilovic, Astrid Jullion, Audrey Kauffmann, Emil Kuriakose, Marion Wiesmann, Michael R Jensen, Francesco Hofmann, William R Sellers
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201. Cancer research 78 (21) (2018)

William R Sellers.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

William R Sellers